Planned trade deal with Europe could keep medicine prices too high
- Written by Belinda Townsend, Research Fellow, NHMRC Centre for Research Excellence in the Social Determinants of Health Equity, School of Regulation and Global Governance, Australian National University
Extending pharmaceutical monopolies would substantially increase costs for taxpayers.Shutterstock
The United States’ withdrawal from the Trans Pacific Partnership and the recent US-China tariff wars have flamed concerns that international trade is becoming unstable.
Trade talks between Australia and the European Union –...
Read more: Planned trade deal with Europe could keep medicine prices too high